Statin therapy at carotid angioplasty and stent placement: Effect on procedure-related stroke, myocardial infarction, and death

Radiology

Volumn 240, Issue 1, 2006, Pages 145-151

  Gröschel, Klaus ^a,b   Ernemann, Ulrike ^a   Schulz, Jörg B ^a   Nägele, Thomas ^a   Terborg, Christoph ^c   Kastrup, Andreas ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CERIVASTATIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BRAIN PROTECTION; CAROTID ARTERY OBSTRUCTION; CHI SQUARE TEST; CONTROLLED STUDY; DATA BASE; DEATH; DEVICE; DRUG EFFECT; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STENT; STROKE; SYMPTOM;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; CAROTID STENOSIS; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 33745120121     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2401050603     Document Type: Article

References (30)

1. Amarenco P, Labreuche J, Lavallee P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004; 35:2902-2909.
2. Chan AW, Bhatt DL, Chew DP, et al. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation 2002; 105:691-696.
3. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2004;110:674-678.
4. Badimon JJ, Ortiz AF, Meyer B, et al. Different response to balloon angioplasty of carotid and coronary arteries: effects on acute platelet deposition and intimal thickening. Atherosclerosis 1998;140:307-314.
5. Biller J, Feinberg WM, Castaldo JE, et al. Guidelines for carotid endarterectomy: a statement for Healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1998; 29:554-562.
6. Kastrup A, Groschel K, Schulz JB, Nägele T, Ernemann U. Clinical predictors of transient ischemic attack, stroke, or death within 30 days of carotid angioplasty and stenting. Stroke 2005;36:787-791.
7. Qureshi AI, Luft AR, Janardhan V, et al. Identification of patients at risk for periprocedural neurological deficits associated with carotid angioplasty and stenting. Stroke 2000;31:376-382.
8. Mathur A, Roubin GS, Iyer SS, et al. Predictors of stroke complicating carotid artery stenting. Circulation 1998;97:1239-1245.
9. Kastrup A, Schulz JB, Raygrotzki S, Groschel K, Ernemann U. Comparison of angioplasty and stenting with cerebral protection versus endarterectomy for treatment of internal carotid artery stenosis in elderly patients. J Vasc Surg 2004;40:945-951.
10. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 2001;21:1712-1719.
11. Dupuis J, Tardif JC, Cernacek P, Theroux P. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: the RECIFE (REduction of Cholesterol in Ischemia and Function of the Endothelium) trial. Circulation 1999;99:3227-3233.
12. Huggins GS, Pasternak RG, Alpert NM, Fischman AJ, Gewirtz H. Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation 1998;98:1291-1296.
13. O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997;95:1126-1131.
14. Lacoste L, Lam JY, Hung J, Letchacovski G, Solymoss CB, Waters D. Hyperlipidemia and coronary disease: correction of the increased thrombogenic potential with cholesterol reduction. Circulation 1995;92:3172-3177.
15. Bustos C, Hernandez-Presa MA, Ortego M, et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol 1998;32:2057-2064.
16. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E; for the Cholesterol and Recurrent Events (CARE) Investigators. Longterm effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999;100:230-235.
17. Walter DH, Fichtischerer S, Sellwig M, Auch-Schwelk W, Schachinger V, Zeiher AM. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 2001; 37:839-846.
18. Schillinger M, Exner M, Mlekusch W, et al. Acute-phase response after stent implantation in the carotid artery: association with 6-month in-stent restenosis. Radiology 2003; 227:516-521.
19. Rothwell PM, Slattery J, Warlow CP. Clinical and angiographic predictors of stroke and death from carotid endarterectomy. systematic review. BMJ 1997;315:1571-1577.
20. Hobson RW, Howard VJ, Roubin GS, et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 2004;40:1106-1111.
21. Roubin GS, New G, Iyer SS, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation 2001;103: 532-537.
22. Rothwell PM, Slattery J, Warlow CP. A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke 1996;27:260-265.
23. Kirsch EC, Khangure MS, van Schie GP, Lawrence-Brown MM, Stewart-Wynne EG, McAuliffe W. Carotid arterial stent placement: results and follow-up in 53 patients. Radiology 2001;220:737-744.
24. Malek AM, Higashida RT, Phatouros CC, et al. Stent angioplasty for cervical carotid artery stenosis in high-risk symptomatic NASCET-ineligible patients. Stroke 2000;31: 3029-3033.
25. McKevitt FM, Macdonald S, Venables GS, Cleveland TJ, Gaines PA. Is the endovascular treatment of carotid stenosis in high-risk patients really safer than carotid endarterectomy? Cerebrovasc Dis 2004;17:332-338.
26. McKevitt FM, Macdonald S, Venables GS, Cleveland TJ, Gaines PA. Complications following carotid angioplasty and carotid stenting in patients with symptomatic carotid artery disease. Cerebrovasc Dis 2004;17:28-34.
27. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001;357:1729-1737.
28. EVA-3S Investigators. Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Stroke 2004;35:e18-e20. http://stroke.ahajournals.org/cgi/content/short/01.STR. 0000106913.33940.DDv1. Accessed July 15, 2004.
29. Ellis SG, Chew D, Chan A, Whitlow PL, Schneider JP, Topol EJ. Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period-importance of creatine kinase-MB level, completeness of revascularization. ventricular function, and probable benefit of statin therapy. Circulation 2002;106:1205-1210.
30. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study-a randomized controlled trial. JAMA 2001;285: 1711-1718.